Eugene Schaefer, Bristol-Myers Squibb, PO Box 5400, Princeton, NJ 08543 and Gregory Frank, Amgen, MS 30W-2-A, One Amgen Center Drive, Thousand Oaks, CA 91320, US.
The uniqueness of this session is reflected in the diverse range of topics coupled with the expertise of the speakers in their fields to address these areas. These opening remarks will relate the importance of these topics to biopharmaceutical development and the rational for the session arrangements. The session will close with an interactive panel discussion.